OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer received an award of 8,315 RGEN derivative securities | OQRO

Home
Insider trades
Repligen
Officer received an award of 8,315 RGEN derivative securities

Insider trades

Insider trade

Officer received an award of 8,315 RGEN derivative securities

Traded Mar 5, 2026 · Filed Mar 23, 2026

RGERepligenRGEN

8,315
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 5, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 23, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193125-26-119034
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Mar 23, 2026, 7:53 PM UTC

Added to OQRO

Oct 6, 2026, 8:46 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

REPLIGEN CORP

Issuer CIK

730272

Ticker

RGEN

Reporting person

James Bylund

Relationship

Officer

Officer title

Chief Operating Officer

Security

Stock Option (Right to Buy)

Table

Derivative (Table II)

Transaction date

Mar 5, 2026

Transaction code

Shares / units

8,315

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

8,315

Ownership form

Direct

Amendment

Footnotes from the filing

One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029.

Around the same time

Olivier Loeillot (Chief Executive Officer) sold ~$536K of Repligen

Scheduled in advanceFiled 6mo ago

Ralf KuriyelSenior VP, R&D

Filed 7mo ago

5,284Shares

Traded Mar 5 · filed 18 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record

Ralf KuriyelSenior VP, R&D

Filed 7mo ago

5,669Derivative units

Traded Mar 5 · filed 18 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record